Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

Huiberts, Anne J; de Gier, Brechje; Hoeve, Christina E; de Melker, Hester E; Hahné, Susan Jm; center, Radboud; van de Wijgert, Janneke Hhm; van den Hof, Susan; Knol, Mirjam J

doi:https://doi.org/10.2807/1560-7917.ES.2023.28.7.2300087

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

DSpace/Manakin Repository

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

Huiberts, Anne J; de Gier, Brechje; Hoeve, Christina E; de Melker, Hester E; Hahné, Susan Jm; center, Radboud; van de Wijgert, Janneke Hhm; van den Hof, Susan; Knol, Mirjam J

(2023) Eurosurveillance, volume 28, issue 7

(Article)

Abstract

We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV-2 infection was 31% in 18-59-year-olds and 14% in 60-85-year-olds. Protection of Omicron ... read more

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: COVID-19, SARS-CoV-2, vaccine effectiveness, Public Health, Environmental and Occupational Health, Epidemiology, Virology

DOI: https://doi.org/10.2807/1560-7917.ES.2023.28.7.2300087

ISSN: 1560-7917

Publisher: Centre Europeen pour la Surveillance Epidemiologique du SIDA

(Peer reviewed)